People are failing to understand ''ínherent'' risk associated with TNR.
If there is no commercial 'gold'' findings TNR can't bring or invent for the waiting investors!
Two days continuous drop is TNR share price shows that TNR is very risky indeed.
DYOR
- Forums
- ASX - By Stock
- ASR
- Cautious approach
Cautious approach, page-51
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASR (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.21M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $9.471K | 1.578M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 24592400 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 6524915 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 24592400 | 0.005 |
17 | 21379372 | 0.004 |
15 | 9143652 | 0.003 |
9 | 10150101 | 0.002 |
8 | 15990150 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 6524915 | 3 |
0.007 | 12671334 | 13 |
0.008 | 4732822 | 9 |
0.009 | 1780201 | 3 |
0.010 | 7977230 | 8 |
Last trade - 10.00am 15/07/2024 (20 minute delay) ? |
Featured News
ASR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online